Since the potential relevance of GSTO1 and GSTO2 polymorphisms in the susceptibility to ovarian cancer has not been clarified as yet, we aimed to investigate whether the presence of different genetic variants of GSTO1 and GSTO2, individually or combined, might represent determinants of risk for OC development. The gene discussed is GSTO1; the disease is ovarian carcinoma.